One of Alfaisal College of Medicine research teams (Dr Ahmad Aljada, Dr Hanaa Hajeer and Dr Rajaa Fakhoury) has been recently accepted into the Panacea OncoStars 19/20 Action initiative, sponsored by Cancer Research UK. This is billed as an engagement, training and translation platform for researchers working in the field of oncology. The team was invited to attend a series of workshops, seminars & mentoring sessions to support the commercial development of their idea regarding the diagnostic value of LMNA/C transcript variants as cancer biomarkers and development of chemotherapeutic sensitizer. The team will be competing for a prize worth £100K.
Panacea OncoStars 19/20 Research Platform
Students
Archives
News Release
Breast cancer workshop
(AlEqtesdaya, Al Jazirah, Al Riyadh :12 April 2010)
COM International Achievement
(AlHayat, Al Riyadh, Al Watan, Al Nadwah: 11 April 2011)
Dallah...
The announcement of the academic program
RIYADH, May 16, 2007 — His Royal Highness Prince Khalid Al Faisal Ibn Abdul Aziz Al Saud, Chairman of the Board of Trustees of...
Memorandum of Understanding between Alfaisal University and the Security Forces Hospital
H.H. Prince Bandar Bin Saud Bin Khalid Al Saud, Chairman of the Executive Committee of the Board of Trustees of Alfaisal University, has signed...
Alfaisal University participates as an official sponsor in the Exhibition of Education and Training
Alfaisal University participated as an official sponsor in the Exhibition of Education and Training, organized by Madarat Alaridh Company from 20 to 23 May...
Swedish Scholarship Program for Saudi Graduates
Sweden is to establish a scholarship program for Saudi graduates and cooperate with the Kingdom in building a new engineering department in Riyadh as...
